Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery

Journal of Hematotherapy and Stem Cell Research

Volumn 6, Issue 1, 1997, Pages 13-19

  Remes, Kari ^a   Matinlauri, Irma ^a   Grenman, Seua ^a   Itälä, Maija ^a   Kauppila, Marjut ^a   Pelliniemi, Tarja Terttu ^a   Salminen, Eeva ^a   Vanharanta, Riitta ^a   Rajamäki, Allan ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL TRANSPLANTATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FOLLOW UP; HEMATOPOIESIS; HUMAN; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

EID: 0030960676     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1997.6.13     Document Type: Article

References (33)

1. Bensinger, W., Singer, J., Appelbaum, F., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993.
2. Schwartzberg, L., Birch, R., Blanco, R., et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant. 11:369, 1993.
3. Langenmayer, I., Weaver, C., Buckner, C.D., et al. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. Bone Marrow Transplant. 15:241, 1995.
4. Tarella, C., Ferrero, D., Bregni, M., et al. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur. J. Cancer 27:22, 1991.
5. Pettengell, R., Testa, N.G., Swindell, R., et al. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239, 1993.
6. Möhle, R., Pförsisch, M., Fruehauf, S., et al. Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant. 14:827, 1994.
7. Siena, S., Bregni, M., Brando, B., et al. Flow cytometry for clinical estimation for circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
8. Scott, M.A. & Gordon, M.Y. In search of the haemopoietic stem cell. Br. J. Haematol. 90:738, 1995.
9. Meagher, R.C. & Herzig, R.H. Techniques of harvesting and cyropreservation of stem cells. Hematol. Oncol. Clin. 7:501, 1993.
10. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
11. Zimmerman, T.M., Lee, W.J., Bender, J.G., et al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant. 9:439, 1995.
12. Rosenfeld, C.S., Cullis, H., Tarosky, T., et al. Peripheral blood stem cell collection using the small volume collection chamber in the Fenwal CS-3000 Plus blood cell separator. Bone Marrow Transplant. 13:131, 1994.
13. Johnsen, H.E., for the Nordic Myeloma Study Group Laboratories. Report from a Nordic Workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J. Hematother. 4:21, 1995.
14. Iscove, N.N., Sieber, F. & Winterhalter, K.H. Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J. Cell Physiol. 83:309, 1974.
15. Guilbert, L.J. & Iscove, N.N. Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature 263:594, 1976.
16. Haas, R., Möhle, R., Murea, S., et al. Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factor. J. Hematother. 3:323, 1994.
17. Fritsch, G., Buchinger, P. & Printz, D. Use of flow cytometric CD34+ analysis to quantify hematopoietic progenitor cells. Leuk. Lymphoma 10:443, 1993.
18. Serke, S., Sauberlich, S. & Huhn, D. Multiparameter flow-cytometrical quantitation of circulating CD34+ cells: Correlation to the quantitation of circulating hemopoietic progenitor cells by in vitro colony assay. Br. J. Haematol. 77:453, 1991.
19. Janssen, W.E., Farmelo, M.J., Lee, C., et al. The CD34+ cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp. Hematol. 20:528, 1992.
20. Jones, H.M., Jones, S.A., Watts, M.J., et al. Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J. Clin. Oncol. 12:1693, 1994.
21. Pettengell, R., Morgenstern, G.R., Woll, P.J., et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993.
22. To, L.B., Shepperd, K.M., Haylock, D.N., et al. Single high doses of cyclophosphamide enable the collection of high numbers of hematopoietic stem cells from the peripheral blood. Exp. Hematol. 18:442, 1990.
23. Brugger, W., Brass, K., Frisch, J., et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 79:1193, 1992.
24. Johnson, P.R.E., Fitzsimmons, C.L., Chang, J., et al. Infection at the time of peripheral blood stem cell leukapheresis results in reduced granulocyte-macrophage colony-forming unit yields. Br. J. Haematol. 89:689, 1995.
25. Hohaus, S., Goldschmidt, H., Ehrhardt, R., et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp. Hematol. 21:508, 1993.
26. Brice, P., Marolleau, J.P., Dombret, H., et al. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Bone Marrow Transplant. 9:337, 1992.
27. Elias, A.D., Ayash, L., Anderson, K.C., et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992.
28. Henon, Ph.R., Liang, H., Beck-Wirth, G., et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 9:285, 1992.
29. Reiffers, J., Faberes, C., Boiron, J.M., et al. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: Analysis of factors affecting the rate of engraftment. J. Hematother. 3:185, 1994.
30. Rosenfeld, C.S., Shadduck, R.K., Zeigler, Z.R., et al. Cyclophosphamide-mobilized peripheral blood stem cells in patients with lymphoid malignancies. Bone Marrow Transplant. 15:433, 1995.
31. To, L.B. & Juttner, C.A. Peripheral blood stem cell autografting: A new therapeutic option for AML? Br. J. Haematol. 66:285, 1987.
32. Gordon, M.Y. & Blackett, N.M. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant. 15:659, 1995.
33. Sheridan, W.P., Begley, C.G., Juttner, C.A., et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992.